Annual Net Income
-$13.32 M
+$6.96 M+34.32%
01 December 2023
Summary:
Plus Therapeutics annual net profit is currently -$13.32 million, with the most recent change of +$6.96 million (+34.32%) on 01 December 2023. During the last 3 years, it has fallen by -$5.08 million (-61.58%). PSTV annual net income is now -537.13% below its all-time high of -$2.09 million, reached on 31 December 1998.PSTV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.87 M
+$66.00 K+2.24%
01 September 2024
Summary:
Plus Therapeutics quarterly net profit is currently -$2.87 million, with the most recent change of +$66.00 thousand (+2.24%) on 01 September 2024. Over the past year, it has increased by +$936.00 thousand (+24.57%). PSTV quarterly net income is now -163.22% below its all-time high of $4.55 million, reached on 30 September 2004.PSTV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$12.88 M
+$345.00 K+2.61%
01 September 2024
Summary:
Plus Therapeutics TTM net profit is currently -$12.88 million, with the most recent change of +$345.00 thousand (+2.61%) on 01 September 2024. Over the past year, it has increased by +$431.00 thousand (+3.24%). PSTV TTM net income is now -1291.95% below its all-time high of $1.08 million, reached on 30 September 2004.PSTV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +24.6% | +3.2% |
| 3 y3 years | -61.6% | +22.8% | -0.4% |
| 5 y5 years | -5.4% | -646.4% | +8.0% |
PSTV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -61.6% | +34.3% | -93.9% | +49.2% | -9.4% | +38.5% |
| 5 y | 5 years | -61.6% | +34.3% | -425.1% | +49.2% | -749.9% | +38.5% |
| alltime | all time | -537.1% | +64.4% | -163.2% | +86.9% | -1292.0% | +73.7% |
Plus Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.87 M(-2.2%) | -$12.88 M(-2.6%) |
| June 2024 | - | -$2.94 M(-9.8%) | -$13.23 M(+12.4%) |
| Mar 2024 | - | -$3.26 M(-14.4%) | -$11.77 M(-11.6%) |
| Dec 2023 | -$13.32 M(-34.3%) | -$3.81 M(+18.4%) | -$13.32 M(-12.2%) |
| Sept 2023 | - | -$3.22 M(+117.2%) | -$15.16 M(-11.7%) |
| June 2023 | - | -$1.48 M(-69.2%) | -$17.16 M(-18.1%) |
| Mar 2023 | - | -$4.80 M(-15.1%) | -$20.96 M(+3.4%) |
| Dec 2022 | -$20.27 M(+51.3%) | -$5.66 M(+8.4%) | -$20.27 M(+8.0%) |
| Sept 2022 | - | -$5.22 M(-1.2%) | -$18.77 M(+8.7%) |
| June 2022 | - | -$5.28 M(+28.3%) | -$17.28 M(+16.8%) |
| Mar 2022 | - | -$4.12 M(-0.9%) | -$14.79 M(+10.4%) |
| Dec 2021 | -$13.40 M(+62.6%) | -$4.16 M(+11.6%) | -$13.40 M(+4.4%) |
| Sept 2021 | - | -$3.72 M(+33.0%) | -$12.83 M(+18.4%) |
| June 2021 | - | -$2.80 M(+2.9%) | -$10.84 M(+9.7%) |
| Mar 2021 | - | -$2.72 M(-24.2%) | -$9.87 M(+19.8%) |
| Dec 2020 | -$8.24 M(-24.3%) | -$3.59 M(+107.6%) | -$8.24 M(+118.6%) |
| Sept 2020 | - | -$1.73 M(-6.0%) | -$3.77 M(+148.7%) |
| June 2020 | - | -$1.84 M(+69.2%) | -$1.52 M(-82.8%) |
| Mar 2020 | - | -$1.09 M(-223.0%) | -$8.82 M(-18.9%) |
| Dec 2019 | -$10.89 M(-13.8%) | $884.00 K(+68.1%) | -$10.89 M(-22.3%) |
| Sept 2019 | - | $526.00 K(-105.8%) | -$14.01 M(-16.9%) |
| June 2019 | - | -$9.15 M(+190.4%) | -$16.86 M(+48.2%) |
| Mar 2019 | - | -$3.15 M(+40.9%) | -$11.38 M(-10.0%) |
| Dec 2018 | -$12.63 M(-44.3%) | -$2.24 M(-4.0%) | -$12.63 M(-14.0%) |
| Sept 2018 | - | -$2.33 M(-36.3%) | -$14.69 M(-14.4%) |
| June 2018 | - | -$3.66 M(-17.0%) | -$17.16 M(-12.2%) |
| Mar 2018 | - | -$4.41 M(+2.8%) | -$19.55 M(-13.8%) |
| Dec 2017 | -$22.69 M(+2.9%) | -$4.29 M(-10.8%) | -$22.69 M(-2.7%) |
| Sept 2017 | - | -$4.81 M(-20.5%) | -$23.32 M(-2.4%) |
| June 2017 | - | -$6.05 M(-19.8%) | -$23.90 M(-1.5%) |
| Mar 2017 | - | -$7.54 M(+53.4%) | -$24.25 M(+10.0%) |
| Dec 2016 | -$22.05 M(+17.6%) | -$4.92 M(-8.6%) | -$22.05 M(+10.8%) |
| Sept 2016 | - | -$5.38 M(-15.9%) | -$19.89 M(+53.2%) |
| June 2016 | - | -$6.41 M(+20.0%) | -$12.98 M(+510.8%) |
| Mar 2016 | - | -$5.34 M(+93.2%) | -$2.13 M(-88.7%) |
| Dec 2015 | -$18.74 M(-49.8%) | -$2.76 M(-280.9%) | -$18.74 M(-13.8%) |
| Sept 2015 | - | $1.53 M(-65.7%) | -$21.74 M(-33.4%) |
| June 2015 | - | $4.45 M(-120.3%) | -$32.65 M(-33.3%) |
| Mar 2015 | - | -$21.96 M(+281.5%) | -$48.93 M(+30.9%) |
| Dec 2014 | -$37.37 M(+42.8%) | -$5.76 M(-38.7%) | -$37.37 M(-10.3%) |
| Sept 2014 | - | -$9.38 M(-20.7%) | -$41.65 M(+11.0%) |
| June 2014 | - | -$11.83 M(+13.7%) | -$37.53 M(+29.8%) |
| Mar 2014 | - | -$10.40 M(+3.6%) | -$28.91 M(+10.4%) |
| Dec 2013 | -$26.18 M(-18.9%) | -$10.04 M(+90.9%) | -$26.18 M(+31.1%) |
| Sept 2013 | - | -$5.26 M(+63.7%) | -$19.96 M(-23.1%) |
| June 2013 | - | -$3.21 M(-58.1%) | -$25.95 M(-15.3%) |
| Mar 2013 | - | -$7.67 M(+100.5%) | -$30.62 M(-5.1%) |
| Dec 2012 | -$32.28 M | -$3.82 M(-66.0%) | -$32.28 M(-8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$11.25 M(+42.7%) | -$35.36 M(+9.0%) |
| June 2012 | - | -$7.88 M(-15.5%) | -$32.45 M(+9.2%) |
| Mar 2012 | - | -$9.32 M(+35.0%) | -$29.70 M(-8.5%) |
| Dec 2011 | -$32.45 M(+18.0%) | -$6.91 M(-17.1%) | -$32.45 M(-6.7%) |
| Sept 2011 | - | -$8.34 M(+62.2%) | -$34.80 M(-5.6%) |
| June 2011 | - | -$5.14 M(-57.4%) | -$36.88 M(-0.6%) |
| Mar 2011 | - | -$12.07 M(+30.5%) | -$37.12 M(+35.0%) |
| Dec 2010 | -$27.49 M(+18.4%) | -$9.25 M(-11.2%) | -$27.49 M(-0.9%) |
| Sept 2010 | - | -$10.42 M(+93.7%) | -$27.73 M(+15.0%) |
| June 2010 | - | -$5.38 M(+119.7%) | -$24.11 M(+23.3%) |
| Mar 2010 | - | -$2.45 M(-74.2%) | -$19.56 M(-15.7%) |
| Dec 2009 | -$23.22 M(-22.7%) | -$9.49 M(+39.5%) | -$23.21 M(+14.6%) |
| Sept 2009 | - | -$6.80 M(+723.5%) | -$20.26 M(-0.1%) |
| June 2009 | - | -$826.00 K(-86.5%) | -$20.27 M(-27.2%) |
| Mar 2009 | - | -$6.10 M(-6.6%) | -$27.86 M(-7.2%) |
| Dec 2008 | -$30.04 M(+4.8%) | -$6.53 M(-4.2%) | -$30.04 M(-12.1%) |
| Sept 2008 | - | -$6.82 M(-19.0%) | -$34.18 M(+4.6%) |
| June 2008 | - | -$8.41 M(+1.7%) | -$32.69 M(+15.6%) |
| Mar 2008 | - | -$8.27 M(-22.5%) | -$28.28 M(-1.4%) |
| Dec 2007 | -$28.67 M(+12.7%) | -$10.68 M(+100.5%) | -$28.67 M(+44.0%) |
| Sept 2007 | - | -$5.33 M(+33.3%) | -$19.91 M(-14.7%) |
| June 2007 | - | -$4.00 M(-53.9%) | -$23.34 M(-12.4%) |
| Mar 2007 | - | -$8.67 M(+353.4%) | -$26.66 M(+4.8%) |
| Dec 2006 | -$25.45 M(-4.1%) | -$1.91 M(-78.2%) | -$25.45 M(-32.9%) |
| Sept 2006 | - | -$8.77 M(+19.9%) | -$37.90 M(+20.6%) |
| June 2006 | - | -$7.31 M(-1.9%) | -$31.42 M(+6.6%) |
| Mar 2006 | - | -$7.46 M(-48.1%) | -$29.47 M(+11.0%) |
| Dec 2005 | -$26.54 M(+1169.8%) | -$14.36 M(+527.8%) | -$26.54 M(+60.9%) |
| Sept 2005 | - | -$2.29 M(-57.3%) | -$16.49 M(+70.8%) |
| June 2005 | - | -$5.36 M(+18.4%) | -$9.66 M(+19.1%) |
| Mar 2005 | - | -$4.53 M(+4.9%) | -$8.11 M(+287.9%) |
| Dec 2004 | -$2.09 M(-77.5%) | -$4.32 M(-194.9%) | -$2.09 M(-293.3%) |
| Sept 2004 | - | $4.55 M(-219.3%) | $1.08 M(-117.3%) |
| June 2004 | - | -$3.81 M(-355.7%) | -$6.26 M(+38.8%) |
| Mar 2004 | - | $1.49 M(-230.1%) | -$4.51 M(-51.4%) |
| Dec 2003 | -$9.28 M(-28.6%) | -$1.15 M(-59.1%) | -$9.28 M(-31.9%) |
| Sept 2003 | - | -$2.80 M(+35.9%) | -$13.64 M(-1.2%) |
| June 2003 | - | -$2.06 M(-37.2%) | -$13.80 M(+3.4%) |
| Mar 2003 | - | -$3.28 M(-40.4%) | -$13.35 M(+2.7%) |
| Dec 2002 | -$13.00 M(+16.0%) | -$5.50 M(+85.4%) | -$13.00 M(+24.8%) |
| Sept 2002 | - | -$2.97 M(+85.0%) | -$10.42 M(+2.3%) |
| June 2002 | - | -$1.60 M(-45.4%) | -$10.19 M(-21.2%) |
| Mar 2002 | - | -$2.93 M(+0.7%) | -$12.93 M(+29.4%) |
| Dec 2001 | -$11.21 M(+29.6%) | -$2.92 M(+6.5%) | -$9.99 M(+41.2%) |
| Sept 2001 | - | -$2.74 M(-37.0%) | -$7.08 M(+63.0%) |
| June 2001 | - | -$4.34 M | -$4.34 M |
| Dec 2000 | -$8.64 M(+89.1%) | - | - |
| Dec 1999 | -$4.57 M(+118.7%) | - | - |
| Dec 1998 | -$2.09 M | - | - |
FAQ
- What is Plus Therapeutics annual net profit?
- What is the all time high annual net income for Plus Therapeutics?
- What is Plus Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Plus Therapeutics?
- What is Plus Therapeutics quarterly net income year-on-year change?
- What is Plus Therapeutics TTM net profit?
- What is the all time high TTM net income for Plus Therapeutics?
- What is Plus Therapeutics TTM net income year-on-year change?
What is Plus Therapeutics annual net profit?
The current annual net income of PSTV is -$13.32 M
What is the all time high annual net income for Plus Therapeutics?
Plus Therapeutics all-time high annual net profit is -$2.09 M
What is Plus Therapeutics quarterly net profit?
The current quarterly net income of PSTV is -$2.87 M
What is the all time high quarterly net income for Plus Therapeutics?
Plus Therapeutics all-time high quarterly net profit is $4.55 M
What is Plus Therapeutics quarterly net income year-on-year change?
Over the past year, PSTV quarterly net profit has changed by +$936.00 K (+24.57%)
What is Plus Therapeutics TTM net profit?
The current TTM net income of PSTV is -$12.88 M
What is the all time high TTM net income for Plus Therapeutics?
Plus Therapeutics all-time high TTM net profit is $1.08 M
What is Plus Therapeutics TTM net income year-on-year change?
Over the past year, PSTV TTM net profit has changed by +$431.00 K (+3.24%)